On Monday, November 9th, the drug company Pfizer announced that its COVID-19 vaccine candidate is more than 90 percent effective at preventing infection. said Monday that early analysis showed its vaccine candidate for Covid-19 is more than 90 percent effective at preventing infection. The company still plans to conduct and complete additional safety studies prior to applying for emergency use authorization from the U.S. Food and Drug Administration, however they expect to have this step complete later this month. The ability to deliver this vaccine on a mass scale remains limited, and is expected to take several months before being universally available.
According to Pfizer, it projects plans to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021. Distributing the vaccine will be a challenging undertaking as it must be kept at super-cold temperatures prior to human delivery.